Nguyen Antoinette, Chon Jeewon, Coles Brigid, Galiano Robert
University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
Loyola University School of Medicine, Chicago, Illinois, USA.
J Surg Oncol. 2024 Dec 10. doi: 10.1002/jso.28014.
Breast cancer is the most commonly diagnosed cancer among women in Southeast Asia. However, significant disparities in access to postmastectomy breast reconstruction persist due to cultural, economic, and healthcare-related factors. These disparities result in unequal access to care, impacting patient outcomes, and overall quality of life. A systematic review was conducted following PRISMA guidelines to assess trends, disparities, and outcomes in breast reconstruction across Southeast Asia. The review included 15 studies published between 2000 and 2023 from countries including Singapore, Malaysia, Vietnam, Thailand, and Brunei. Data extracted focused on disparities related to ethnicity, socioeconomic status, geographic location, and surgical outcomes. Statistical analysis included summarizing key variables across studies. Significant cultural and economic barriers to breast reconstruction were identified. Cultural beliefs influenced uptake, with Malay women preferring autologous tissue reconstruction (92.3%), while Chinese women had lower reconstruction rates due to traditional beliefs. Economic constraints limited access to advanced techniques like the DIEP flap, which had a median cost of SGD 11 009.38, significantly higher than the TRAM flap (SGD, 300.51, p < 0.001). Geographic disparities further restricted access, especially in rural areas. Complication rates were higher in obese patients, with total flap loss at 6% and fat necrosis at 10%. Studies from Vietnam and Thailand reported 5-year overall survival rates of 95% and disease-free survival rates of 80.7% for early-stage breast cancer patients undergoing reconstruction. Breast reconstruction disparities in Southeast Asia are driven by complex interactions between cultural, economic, and healthcare-related factors. Efforts to reduce these disparities must focus on increasing patient education, expanding reconstructive options, and addressing systemic healthcare inequalities. Targeted interventions, including policy changes to subsidize reconstruction and improve surgeon training in rural areas, are critical to ensuring equitable access and improving patient outcomes across the region.
乳腺癌是东南亚女性中最常被诊断出的癌症。然而,由于文化、经济和医疗相关因素,乳房切除术后乳房重建的可及性存在显著差异。这些差异导致获得护理的机会不平等,影响患者的治疗结果和整体生活质量。按照PRISMA指南进行了一项系统综述,以评估东南亚地区乳房重建的趋势、差异和结果。该综述纳入了2000年至2023年间发表的15项研究,这些研究来自新加坡、马来西亚、越南、泰国和文莱等国家。提取的数据聚焦于与种族、社会经济地位、地理位置和手术结果相关的差异。统计分析包括总结各项研究中的关键变量。研究发现了乳房重建存在的重大文化和经济障碍。文化信仰影响了接受程度,马来女性更倾向于自体组织重建(92.3%),而中国女性由于传统观念,重建率较低。经济限制使人们难以获得像腹壁下动脉穿支皮瓣(DIEP瓣)这样的先进技术,其平均成本为11,009.38新元,显著高于横行腹直肌肌皮瓣(TRAM瓣,300.51新元,p < 0.001)。地理差异进一步限制了可及性,尤其是在农村地区。肥胖患者的并发症发生率更高,皮瓣完全坏死率为6%,脂肪坏死率为10%。越南和泰国的研究报告称,接受重建的早期乳腺癌患者的5年总生存率为95%,无病生存率为80.7%。东南亚地区乳房重建的差异是由文化、经济和医疗相关因素之间的复杂相互作用驱动的。减少这些差异的努力必须集中在加强患者教育、扩大重建选择以及解决系统性医疗不平等问题上。有针对性的干预措施,包括通过政策变化为重建提供补贴以及改善农村地区外科医生的培训,对于确保整个地区公平获得治疗并改善患者治疗结果至关重要。